RHO and retinitis pigmentosa 1: Targeted gene therapy is promising for RHO-associated RP; however, it requires the inhibition of mutant RHO protein expression with simultaneously increasing the wild-type-to-mutant RHO ratio to effectively reduce the rate of retinal degeneration.